Insider Shareholders with Direct Ownership of Eye Point Pharmaceuticals, Inc. (EYPT)
This section provides a comprehensive overview of the insiders with direct ownership of Eye Point Pharmaceuticals, Inc. (EYPT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
EyePoint Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Therapeutics Ocumension
Director |
0 | 2,910,500 | 100,221 $711,569 | 3 |
Jan 11, 2024
Reduced 95.02%
|
| 238,884 | 177,667 | 97,635 $693,208 | 18 |
Aug 16, 2024
Added 3.15%
|
|
|
Dario A. Paggiarino
Chief Medical Officer |
223,192 | 165,022 | 67,080 $476,268 | 30 |
Mar 30, 2024
Reduced 9.57%
|
|
George Elston
Chief Financial Officer |
49,351 | 13,451 | 47,480 $337,108 | 9 |
May 25, 2024
Reduced 7.1%
|
|
David Scott Jones
SVP & Chief Commercial Officer |
121,587 | 88,256 | 44,916 $318,903 | 24 |
Feb 09, 2024
Reduced 3.65%
|
|
Jay S. Duker
President and CEO |
81,617 | 49,247 | 38,027 $269,991 | 13 |
Jul 10, 2024
Reduced 17.49%
|
| 16,500 | 0 | 16,500 $117,150 | 3 |
Aug 19, 2024
Added 43.1%
|
|
|
Michael Craig Pine
Chief Corp Dev.&Strat. Officer |
61,285 | 50,966 | 13,662 $97,000 | 5 |
Jan 06, 2024
Reduced 30.4%
|
| 13,150 | 0 | 13,150 $93,365 | 4 |
Aug 21, 2024
Added 27.55%
|
|
| 7,400 | 0 | 11,400 $80,940 | 3 |
Feb 09, 2023
Added 20.83%
|
|
| 9,967 | 0 | 9,967 $70,765 | 4 |
Aug 20, 2024
Added 20.48%
|
|
| 4,400 | 0 | 8,016 $56,913 | 2 |
Jun 22, 2021
Added 23.77%
|
|
| 4,000 | 0 | 4,000 $28,400 | 2 |
Jun 23, 2024
Added 33.33%
|
|
| 36,725 | 34,875 | 1,850 $13,135 | 9 |
Jul 12, 2024
Reduced 86.27%
|